Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?

BACKGROUND: The rising number of infections due to Severe Acute Respiratory Syndrome Coronavirus-2 (popularly known as COVID-19) has brought to the fore new antiviral drugs as possible treatments, including favipiravir. However, there is currently no data regarding the safety of this drug in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozsurekci, Yasemin, Oygar, Pembe Derin, Gürlevik, Sibel Laçinel, Kesici, Selman, Ozen, Seza, Kurt Sukur, Eda Didem, Gülhan, Bora, Topaloglu, Rezan, Bayrakci, Benan, Cengiz, Ali Bülent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140325/
https://www.ncbi.nlm.nih.gov/pubmed/34021797
http://dx.doi.org/10.1007/s00467-021-05111-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140325/
https://www.ncbi.nlm.nih.gov/pubmed/34021797
http://dx.doi.org/10.1007/s00467-021-05111-x

Ejemplares similares